Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver

NCT04976283 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
NASH - Nonalcoholic Steatohepatitis
NAFLD

Interventions

DRUG: Pioglitazone
DRUG: Empagliflozin
DRUG: Pioglitazone + Empagliflozin

Sponsor

Getz Pharma